Close Menu

cell-based assays

NEW YORK (GenomeWeb News) – Cellectricon and Fluxion Biosciences announced today they have settled a legal dispute dating back to 2009 in which Fluxion was accused of patent infringement.

NEW YORK (GenomeWeb News) – The National Heart, Lung, and Blood Institute plans to provide $5 million over the next two years to fund research projects aimed at developing better and cheaper methods for screening genetic variants that play roles in diseases.

NEW YORK (GenomeWeb News) – BioSeek today said that the US Environmental Protection Agency has extended the firm's contract to participate in the ToxCast screening program.

NEW YORK (GenomeWeb News) – Medicyte and Reinnervate today announced a collaboration to combine their technologies, bringing a next generation of cell-based assays to the biopharma and academic research markets.

NEW YORK (GenomeWeb News) – Affymetrix announced after the close of the market Monday that it has completed the $315 million acquisition of eBioscience.

NEW YORK (GenomeWeb News) – Horizon Discovery and biopharmaceutical firm H3 Biomedicine today announced a collaboration to identify and validate a panel of novel cancer drug targets.

NEW YORK (GenomeWeb News) – Corning today announced an agreement to purchase the majority of Becton Dickinson's Discovery Labware unit for $730 million in cash.

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific today said that it will exclusively distribute BellBrook Labs' iuvo Microconduit Array products.

Pages

Researchers are developing a breath test to determine how severe patients' methylmalonic acidemia disease is, FierceBiotech reports.

NPR reports that vaccine developers are working on SARS-CoV-2 vaccines that are easier to store or administer than the current crop.

Reuters reports that France is to recommend that people under 55 who received one dose of AstraZeneca's SARS-CoV-2 vaccine receive a different vaccine for their second dose.